MXPA04001677A - Sistema terapeutico transdermico con base en adhesivos de poliacrilato de union por contacto sin grupos funcionales. - Google Patents

Sistema terapeutico transdermico con base en adhesivos de poliacrilato de union por contacto sin grupos funcionales.

Info

Publication number
MXPA04001677A
MXPA04001677A MXPA04001677A MXPA04001677A MXPA04001677A MX PA04001677 A MXPA04001677 A MX PA04001677A MX PA04001677 A MXPA04001677 A MX PA04001677A MX PA04001677 A MXPA04001677 A MX PA04001677A MX PA04001677 A MXPA04001677 A MX PA04001677A
Authority
MX
Mexico
Prior art keywords
polyacrylate
functional groups
therapeutic system
transdermal therapeutic
contact
Prior art date
Application number
MXPA04001677A
Other languages
English (en)
Spanish (es)
Inventor
Hildegard Klein Ursula
Original Assignee
Lts Lohmann Therapie Systems A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7696570&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA04001677(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lts Lohmann Therapie Systems A filed Critical Lts Lohmann Therapie Systems A
Publication of MXPA04001677A publication Critical patent/MXPA04001677A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
MXPA04001677A 2001-08-24 2002-08-13 Sistema terapeutico transdermico con base en adhesivos de poliacrilato de union por contacto sin grupos funcionales. MXPA04001677A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10141652A DE10141652B4 (de) 2001-08-24 2001-08-24 Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung
PCT/EP2002/009057 WO2003017988A1 (de) 2001-08-24 2002-08-13 Transdermales therapeutisches system auf der basis von polyacrylat-haftklebern ohne funktionelle gruppen

Publications (1)

Publication Number Publication Date
MXPA04001677A true MXPA04001677A (es) 2004-05-31

Family

ID=7696570

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04001677A MXPA04001677A (es) 2001-08-24 2002-08-13 Sistema terapeutico transdermico con base en adhesivos de poliacrilato de union por contacto sin grupos funcionales.

Country Status (13)

Country Link
US (1) US20040241219A1 (enExample)
EP (1) EP1418895B1 (enExample)
JP (1) JP4393188B2 (enExample)
KR (1) KR100920599B1 (enExample)
CN (1) CN1239153C (enExample)
AU (1) AU2002327831B2 (enExample)
BR (1) BRPI0211993B8 (enExample)
CA (1) CA2455064C (enExample)
DE (1) DE10141652B4 (enExample)
ES (1) ES2397920T3 (enExample)
MX (1) MXPA04001677A (enExample)
WO (1) WO2003017988A1 (enExample)
ZA (1) ZA200400312B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019068288A1 (de) 2017-10-04 2019-04-11 Berlimed International Research Gmbh Wirkstoff und wirkstoffmatrix enthaltendes produkt zur transdermalen wirkstoffabgabe sowie dessen herstellung und verwendung sowie die wirkstoffmatrix, ihre herstellung und verwendung

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9056060B2 (en) 2000-09-19 2015-06-16 Henkel Ag & Co. Kgaa Non-reactive adhesive useful in transdermal drug delivery system
DE10141650C1 (de) * 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
TW200514579A (en) * 2003-07-24 2005-05-01 Smithkline Beecham Corp Orally dissolving films
US20070196455A1 (en) * 2004-04-13 2007-08-23 Saitama Daiichi Pharmaceutical Co., Ltd. Crosslinkable pressure-sensitive adhesive for skin
CN1329022C (zh) * 2004-08-31 2007-08-01 贵州太和制药有限公司 亲水性生物粘附凝胶贴剂及其制备工艺
RU2385719C2 (ru) * 2005-03-12 2010-04-10 Унилевер Нв Композиции для ухода за волосами и/или кожей головы, включающие виснадин
CN1320006C (zh) * 2005-03-24 2007-06-06 上海交通大学 包含酯基部分带酯基基团的丙烯酸酯的组合物
CN1320005C (zh) * 2005-03-24 2007-06-06 上海交通大学 包含酯基部分带烷烃基的丙烯酸酯的组合物
CN1320008C (zh) * 2005-03-24 2007-06-06 上海交通大学 包含酯基部分带羧基基团的丙烯酸酯的组合物
CN1326894C (zh) * 2005-03-24 2007-07-18 上海交通大学 包含酯基部分带烷氧基的丙烯酸酯的组合物
CN1320009C (zh) * 2005-03-24 2007-06-06 上海交通大学 包含酯基部分带羟基基团的丙烯酸酯的组合物
DE102006050558B4 (de) 2006-10-26 2009-03-26 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System enthaltend Norelgestromin zur Kontrazeption und Hormonsubstitution
KR100956023B1 (ko) * 2007-09-28 2010-05-06 대화제약 주식회사 산성 관능기를 갖는 아크릴레이트계 고분자의 함량으로약물 방출속도를 제어하는 툴로부테롤 경피 투여용 패취제
DE102008013701A1 (de) * 2008-03-11 2009-09-17 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System mit stabilisierter Membran
US20100087768A1 (en) * 2008-10-02 2010-04-08 Forlano Paula Transdermal drug delivery system for liquid active ingredient
US10076502B2 (en) 2009-12-22 2018-09-18 Luye Pharma Ag Transdermal therapeutic system for administering rivastigmine or derivatives thereof
MX350357B (es) * 2009-12-22 2017-09-05 Luye Pharma Ag Sistema terapeutico transdermico para administrar rivastigmina o derivados de este.
CN101967213A (zh) * 2010-09-29 2011-02-09 北京化工大学 低分子量带有羧基的聚丙烯酸酯丙烯酸酯的制备方法
EP2468274B1 (de) 2010-12-14 2015-07-01 Acino AG Transdermales therapeutisches System zur Verabreichung eines Wirkstoffs
CA2856520C (en) 2011-11-23 2021-04-06 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
AR100562A1 (es) 2014-05-22 2016-10-12 Therapeuticsmd Inc Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
AU2017239645A1 (en) 2016-04-01 2018-10-18 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
JP6912876B2 (ja) * 2016-10-06 2021-08-04 三洋化成工業株式会社 アクリル系医薬固形製剤用添加剤
DE102017115701B4 (de) * 2017-07-12 2022-03-03 Lts Lohmann Therapie-Systeme Ag Fampridin-TTS
DE102018130469A1 (de) 2018-11-30 2020-06-04 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit Diffusionsbarriere
DE102019120403A1 (de) 2019-07-29 2021-02-04 Lts Lohmann Therapie-Systeme Ag Verfahren zur Herstellung von Haftklebemassen zur Verwendung in einem transdermalen therapeutischen System
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2693212B2 (ja) * 1989-03-28 1997-12-24 日東電工株式会社 疾患治療用テープ製剤
AU644815B2 (en) * 1989-09-08 1993-12-23 Ortho-Mcneil Pharmaceutical, Inc. Solid matrix system for transdermal drug delivery
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
CA2039586A1 (en) * 1990-05-02 1991-11-03 Marian R. Appelt Crosslinked pressure-sensitive adhesives tolerant of alcohol-based excipients used in transdermal delivery devices and method of preparing same
IT1253265B (it) * 1991-11-25 1995-07-14 Rotta Research Lab Preparato a matrice copolimerica adesiva a base acrilica per il rilascio transdermico dell'estradiolo.
WO1993010722A2 (en) * 1991-11-26 1993-06-10 Research Development Foundation Fetal membrane tubes for nerve and vessel grafts
DE4301783C1 (de) * 1993-01-23 1994-02-03 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Galanthamin als wirksamem Bestandteil
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
EP0813865B1 (de) * 1993-04-20 2001-09-19 Hexal Ag Wirkstoffpflaster
JPH09503997A (ja) * 1993-07-08 1997-04-22 シグナス，インコーポレイテッド モノリシックなマトリックス経皮送達システム
US5554381A (en) * 1993-08-09 1996-09-10 Cygnus, Inc. Low flux matrix system for delivering potent drugs transdermally
ES2122140T3 (es) * 1993-12-30 1998-12-16 Rotta Res Bv Parche transdermico con dinitrato de isosorbida como ingrediente activo.
DE4403487C2 (de) * 1994-02-04 2003-10-16 Lohmann Therapie Syst Lts Arznei-Pflaster mit UV-vernetzbaren Acrylat-Copolymeren
US5614210A (en) * 1995-03-31 1997-03-25 Minnesota Mining And Manufacturing Company Transdermal device for the delivery of alfuzosin
SE504430C2 (sv) 1995-06-20 1997-02-10 Ericsson Telefon Ab L M Magasin
JPH1036265A (ja) * 1996-07-19 1998-02-10 Nitto Denko Corp ブプレノルフィン経皮吸収製剤
US5928666A (en) * 1996-11-12 1999-07-27 Cygnus Inc. Crystalline form of estradiol and pharmaceutical formulations comprising same
US6210705B1 (en) * 1997-12-15 2001-04-03 Noven Pharmaceuticals, Nc. Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
DE19814084B4 (de) * 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
DE19830651A1 (de) * 1998-07-09 2000-01-13 Lohmann Therapie Syst Lts Steroidhaltiges Pflaster, Verfahren zu seiner Herstellung und Verwendung
WO2000041538A2 (en) * 1999-01-14 2000-07-20 Noven Pharmaceuticals, Inc. Dermal compositions
ATE287711T1 (de) 1999-11-29 2005-02-15 Novosis Ag Transdermalsystem zur abgabe von clonidin
DE10032537A1 (de) * 2000-07-05 2002-01-31 Labtec Gmbh Dermales System, enthaltend 2-(3-Benzophenyl)Propionsäure
US9056060B2 (en) * 2000-09-19 2015-06-16 Henkel Ag & Co. Kgaa Non-reactive adhesive useful in transdermal drug delivery system

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019068288A1 (de) 2017-10-04 2019-04-11 Berlimed International Research Gmbh Wirkstoff und wirkstoffmatrix enthaltendes produkt zur transdermalen wirkstoffabgabe sowie dessen herstellung und verwendung sowie die wirkstoffmatrix, ihre herstellung und verwendung

Also Published As

Publication number Publication date
WO2003017988A1 (de) 2003-03-06
BR0211993A (pt) 2004-09-28
EP1418895B1 (de) 2012-12-19
CA2455064A1 (en) 2003-03-06
CN1239153C (zh) 2006-02-01
DE10141652B4 (de) 2011-04-07
ES2397920T3 (es) 2013-03-12
JP4393188B2 (ja) 2010-01-06
BRPI0211993B1 (pt) 2017-04-11
US20040241219A1 (en) 2004-12-02
JP2005503390A (ja) 2005-02-03
ZA200400312B (en) 2004-11-01
DE10141652A1 (de) 2003-03-13
CA2455064C (en) 2010-08-03
EP1418895A1 (de) 2004-05-19
KR20040044477A (ko) 2004-05-28
KR100920599B1 (ko) 2009-10-08
AU2002327831B2 (en) 2007-10-25
HK1069533A1 (en) 2005-05-27
BRPI0211993B8 (pt) 2021-07-27
CN1545408A (zh) 2004-11-10

Similar Documents

Publication Publication Date Title
MXPA04001677A (es) Sistema terapeutico transdermico con base en adhesivos de poliacrilato de union por contacto sin grupos funcionales.
WO1996008229A3 (en) Matrix for transdermal drug delivery
AU2002327831A1 (en) Transdermal therapeutic system based on polyacrylate-contact-bonding adhesives without functional groups
DE602005027190D1 (de) Acrylhaftklebstoffzusammensetzung für polarisationsfolie
WO2003018075A3 (de) Transdermales therapeutisches system mit fentanyl bzw. verwandten substanzen
NO20004859D0 (no) Transdermale, terapeutiske systemer (TTS) inneholdende pergolid
GB2427052A (en) System and method for mapping instructions associated with haptic feedback
ATE327296T1 (de) Druckempfindliche klebstoffe und sternblockpolymere und acrylpolymere enthaltende gegenstände
WO2006029740A3 (de) Transdermales therapeutisches system mit einer haftschicht, verfahren zum silikonisieren einer rückschicht des systems und verwendung der rückschicht
NO982764L (no) Oppfinnelse og anordning for transdermal anordning for avgivelse av flurbiprofen
AP2003002890A0 (en) Therapeutic combinations for cardiovascular and inflammatory indications.
BR0010618A (pt) Sistema terapêutico transdermal (tts), que contém tolterodina
TW200608063A (en) Optical film with surface protective film and image display apparatus
CA2321461A1 (en) Cross-linked high amylose starch having functional groups as a matrix for the slow release of pharmaceutical agents
TW200516128A (en) Pressure-sensitive adhesive tape
PL1656433T3 (pl) Taśma samoprzylepna i kompozycja samoprzylepna do medycznych taśm samoprzylepnych
HUP0303311A2 (hu) Hatóanyagként nikotint tartalmazó nagy flexibilitású transzdermális terápiás rendszer
EP1545605B8 (en) Composition for vaccination
DE69704654D1 (de) Drucksensitive klebmittel und diese verwendende selbstklebefilm
AU4764800A (en) Transdermal device for the application of testosterone or one of the derivativesthereof
BRPI0011135B8 (pt) sistema de ministração terapêutica transdérmica contendo agente neuroléptico
SI0955336T1 (en) Polymer blend for the preparation of pressure sensitive adhesive
AU4415300A (en) Method for controlling the fidelity and the execution of reverse transcriptase by incorporating and polymerising nucleotide analogues accepted as substrates of the reverse transcription response without blocking its elongation
AU2003206179A1 (en) An extract of acanthopanax koreanum for the treatment or prevention of hepatitis or the liver protective drug
EP2438912A3 (de) Pflaster, enthaltend Fentanylum

Legal Events

Date Code Title Description
FG Grant or registration